Capital Iron & Steel

Shougang Group, historically known as Capital Iron & Steel, is a major Chinese state-owned enterprise that has diversified from traditional steel manufacturing into the life sciences and biotechnology sectors. The company's flagship biotech subsidiary, Beijing Shougang LanzaTech Technology, is a global pioneer in synthetic biology and carbon capture, utilizing a proprietary gas fermentation platform to convert industrial waste gases into sustainable ethanol and high-quality microbial protein for animal feed. Additionally, the group operates an extensive healthcare network, including the Peking University Shougang Hospital, and provides medical services and health management across China. This strategic transition positions Shougang as a key player in industrial decarbonization and the circular economy, leveraging biological conversion technologies to create value from waste carbon.